Outlook Therapeutics, Inc.
Industry: Biotechnology (See others in industry)
Address:
111 S. Wood Avenue Unit #100
Iselin, NJ, 08830
Phone: 6096193990
Iselin, NJ, 08830
Phone: 6096193990
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-07 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2025-01-27 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2024-04-16 | New | $5,000,002 | $5,000,002 | Equity Only | 06b | SEC link |
| 2024-03-29 | New | $60,000,000 | $60,000,000 | Equity Only | 06b | SEC link |
| 2023-01-06 | New | $1,031,510 | $1,031,510 | Other | 06b | SEC link |
| 2023-01-06 | New | $31,820,000 | $31,820,000 | Debt Only | 06b | SEC link |
| 2021-02-12 | New | $4,013,627 | $4,013,627 | Equity Only | 06b | SEC link |
| 2020-06-09 | New | $16,000,000 | $16,000,000 | Equity Only | 06b | SEC link |
| 2020-03-11 | New | $7,971,155 | $7,971,155 | Equity Only | 06b | SEC link |
| 2017-09-25 | New | $3,262,800 | $3,262,800 | Equity Only | 06b | SEC link |
| 2015-12-23 | New | $6,345,960 | $6,345,960 | Equity Only | 06b | SEC link |
| 2015-10-13 | New | $14,480,486 | $14,480,486 | Equity Only | 06b | SEC link |
| 2015-08-10 | New | $31,050,000 | $31,050,000 | Equity Only | 06b | SEC link |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Gerd Auffarth | Director |
| Kenneth M. Bahrt | Executive |
| Todd C. Brady | Director |
| Scott Canute | Director |
| Terry Dagnon | Executive |
| Albert D. Dyrness | Director |
| Jeff Evanson | Executive |
| Scott A. Gangloff | Executive |
| Julian Gangolli | Director |
| Donald J. Griffith | Director |
| Yezan Haddadin | Director |
| Julia A. Haller | Director |
| Kurt J. Hilzinger | Director |
| Robin Hoke | Director |
| Andong Huang | Director |
| Lawrence A. Kenyon | Director, Executive |
| Stephen J. Mc Andrew | Executive |
| Pankaj Mohan | Director, Executive |
| Faisal G. Sukhtian | Director |
| Joe Thomas | Director |
| Randy H. Thurman | Director |
| C. Russell Trenary | Director, Executive |
| Elizabeth Yamashita | Executive |